SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-013260
Filing Date
2023-04-18
Accepted
2023-04-18 16:00:19
Documents
4
Period of Report
2023-06-16

Document Format Files

Seq Description Document Type Size
1 PRE 14A preliminary_2023_proxy.htm PRE 14A 1075516
2 GRAPHIC img89663703_0.jpg GRAPHIC 5549
3 GRAPHIC img89663703_1.jpg GRAPHIC 118115
4 GRAPHIC img89663703_2.jpg GRAPHIC 113016
  Complete submission text file 0000950170-23-013260.txt   1402927
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39527 | Film No.: 23826762
SIC: 2834 Pharmaceutical Preparations